Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 24, 2025 (1 years ago)

Kofal (Methyl Salicylate)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

KOFAL, Athletes, Penetrating Pain Relief, External Analgesic Ointment (methyl salicylate 10.5% - External Analgesic), 2 oz (60 g) Jar, Distributed by: Pharmadel LLC, New Castle, DE 19720, NDC 55758-109-02, UPC 8 99711 00101 3.

Affected NDC 55758-0109-02

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Kofal
Methyl Salicylate
NDC 55758-0109
10.5 g/100g Ointment
Topical
Pharmadel LLC OTC
Recalling firm
Kenil Healthcare Private Limited
NDC code
55758-109-02
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0426-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Kenil Healthcare Private Limited

All 2025 recalls
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-05 D-0440-2025
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-07 D-0437-2025

Other cgmp deviation recalls from 2025

All cgmp deviation recalls
Class II · Moderate risk

TPN bag (patient specific)

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Ongoing cGMP deviation Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles D-0524-2026
Class II · Moderate risk

Toothpaste: a) COLGATE

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0287-2026
Class II · Moderate risk

Deodorant: a) Axe

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0286-2026